PXEN Prospex Energy Plc

 

1.         STATUTORY INFORMATION

Prospex Energy Plc is a public limited company, is registered in England and Wales and is quoted on the AIM Market of the London Stock Exchange Plc.  The Company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£), rounded to the nearest £1.

2.         ACCOUNTING POLICIES

            Basis of preparation

The Company's financial statements have been prepared in accordance with International Accounting Standards in conformity with the requirements of the Companies Act 2006 as they apply to the financial statements of the Company for the year ended 31 December 2023 and as applied in accordance with the provisions of the Companies Act 2006.

The Company financial statements have been prepared under the historical cost convention or fair value where appropriate.

            Preparation of consolidated financial statements

The Company is an investment entity and, as such, does not consolidate the investment entities it controls.  The Company's interests in subsidiaries are recognised at fair value through profit and loss.

            Going concern

The Company has reported an operating loss for the 2023 year of £1,371,768.  In 2024 it is expected that the Company will have increased receipts resulting from ongoing gas sales from its investment in Italy.  These receipts will initially be received as loan repayments together with interest charged, reimbursing the Company for capital advances made in prior years which were applied to acquisition, exploration and development costs.  As a result, it is expected that the Company will again record an operating loss during 2024, but an increase in cash inflows and balance sheet strength.

The Directors have prepared detailed financial forecasts and cash flows looking beyond 12 months from the date of the approval of these financial statements.  In developing these forecasts, the Directors have made assumptions based upon their view of the current and future economic conditions that are expected to prevail over the forecast period.  The Directors estimate that the cash held by the Company together with known receivables and anticipated income from its Italian asset will be sufficient to support the current budgeted activities in 2024.  Furthermore, the Company's asset in Spain is fully self-funding at current operating levels and is expected to have sufficient cash resources and income to fund existing operations beyond the end of 2024.

The Board expects to raise additional funding only as and when required to cover any shortfall between the Group's own cash resources and its development and expansion of activities.  Should regulatory approval be received which allows for an expansion of current operations, or appropriate new investment opportunities arise which meet the Company's objectives and criteria, then the Directors will explore all potential sources of funding available to meet such shortfall.  Based on the Company's track-record, assets and prospects, the Directors have a reasonable expectation that they will be able to secure such further funding should the need arise.

The Directors have therefore prepared the financial statements on a going concern basis. 

            Property, plant and equipment

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Computer equipment

-

25% per annum on reducing balance

            Financial instruments

Financial assets and financial liabilities are recognised on the statement of financial position when the Company becomes a party to the contractual provisions of the instrument.

Loans and receivables

These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market.  The principal financial assets of the Company are loans and receivables, which arise principally through the provision of goods and services to customers (e.g. trade receivables) but also incorporate other types of contractual monetary asset.  They are included in current assets, except for maturities greater than 12 months after the statement of financial position date.  These are classified as non-current assets.

The Company's loans and receivables are recognised and carried at the lower of their original amount less an allowance for any doubtful amounts.  An allowance is made when collection of the full amount is no longer considered possible.

The Company's loans and receivables comprise trade and other receivables and cash and cash equivalents in the consolidated statement of financial position.

 

2.         ACCOUNTING POLICIES -

 

            Financial liabilities and equity

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into.  An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities.  Financial liabilities are presented as such in the statement of financial position.  Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account.  Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument.  Dividends and distributions relating to equity instruments are debited direct to equity.

Equity comprises the following:

- Share capital represents the nominal value of equity shares;

- Share premium represents the excess over nominal value of the fair value of consideration received for equity shares, net of expenses of the share issue;

- Profit and loss reserve represents retained deficit;

- The capital redemption reserve arises on redemption of shares in previous years and own share reserve;

- Merger reserve represents the difference between the nominal value of the share capital issued by the Company and the fair value of the subsidiary at the date of acquisition;

- Fair value reserve represents the cumulative fair value changes of the company's fixed asset investment, net of deferred tax.

           

            Leases

      Leases are recognised as finance leases.  The lease liability is initially recognised at the present value of the lease payments which have not yet been made and subsequently measured under the amortised cost method. The initial cost of the right-of-use asset comprises the amount of the initial measurement of the lease liability, lease payments made prior to the lease commencement date, initial direct costs and the estimated costs of removing or dismantling the underlying asset per the conditions of the contract.

      Where ownership of the right-of-use asset transfers to the lessee at the end of the lease term, the right-of-use asset is depreciated over the asset's remaining useful life.  If ownership of the right-of-use asset does not transfer to the lessee at the end of the lease term, depreciation is charged over the shorter of the useful life of the right-of-use asset and the lease term.

            Taxation

Current taxes are based on the results shown in the financial statements and are calculated according to local tax rules, using tax rates enacted or substantially enacted by the statement of financial position date.

Deferred tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes.  Deferred tax is determined using tax rates that have been enacted or substantially enacted at the balance sheet date and are expected to apply when the related deferred income tax asset is realised, or the deferred tax liability is settled.  Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited to equity, in which case the deferred tax is also dealt with in equity.  Deferred tax assets are only recognised to the extent that it is probable that future taxable profit will be available against which the asset can be utilised.

            Cash and cash equivalents

Cash and cash equivalents include cash at bank and in hand and short-term deposits with an original maturity of three months or less.

Trade and other payables

Trade and other payables are initially measured at fair value and subsequently measured at amortised cost using the effective interest rate method.

            Foreign currency translation

Items included in the Financial Statements are measured using the currency of the primary economic environment in which the Company operates (the functional currency) which is UK sterling (£).  The Financial Statements are accordingly presented in UK Sterling.

Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions or at an average rate for a period if the rates do not fluctuate significantly.  Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of Profit or Loss.  Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

            Finance income and finance costs

Finance income is recognised when it is probable that the economic benefits will flow to the Company and the amount of income can be measured reliably.  It is accrued on a time basis by reference to the principal outstanding and at the effective interest rate applicable.

Borrowing costs are recognised as an expense in the period in which they are incurred.

            Equity-settled share-based payment

The Company makes equity-settled share-based payments.  The fair value of options granted is recognised as an expense, with a corresponding increase in equity.  The fair value is measured at grant date and spread over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied.  The fair value of the options granted is measured based on the Black-Scholes framework, taking into account the terms and conditions upon which the instruments were granted.  At each statement of financial position date, the Company revises its estimate of the number of options that are expected to become exercisable.  It recognises the impact of the revision to original estimates, if any, in the income statement, with a corresponding adjustment to equity.

            Accounting standards issued but not yet effective and/or adopted

As at the date of approval of these financial statements, the following standards were in issue but not yet effective.  These standards have not been adopted early by the Company as they are not expected to have a material impact on the Company's financial statements.

 

		Effective date (period beginning on or after)
IFRS S1	General requirements for Disclosure of Sustainability-related Financial Information	01/01/2024
IFRS S2	Climate-related Disclosures	01/01/2024
IAS 1	Amendment - Classification of Liabilities as Current or Non-Current	01/01/2024
IFRS 16	Amendment - Lease Liability in a Sale and Leaseback	01/01/2024
IAS 1	Amendment - Non-current Liabilities with Covenants	01/01/2024
IAS 7, IFRS 7	Amendment - Supplier Finance Arrangements	01/01/2024
IAS 21	Amendment - Lack of Exchangeability	01/01/2025
SASB Standards	Amendment - To enhance SASB standards international applicability	01/01/2025

 

The International Financial Reporting Interpretations Committee has also issued interpretations which the Company does not consider will have a significant impact on the financial statements.

            Revenue recognition

Revenue is measured at the fair value of consideration receivable, net of any discounts and VAT.  It is recognised to the extent that the transfer of promised services to a customer has been satisfied and the revenue can be reliably measured.

Revenue from the rendering of services to the customer is considered to have been satisfied when the service has been undertaken.

Revenue which is not related to the principal activity of the Company is recognised in the Statement of Profit or Loss as other operating income.  Such income includes consultancy fees and rent receivable. 

3.         CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

The preparation of the financial information in conformity with IFRS requires the use of certain critical accounting estimates that affect the reported amounts of assets and liabilities at the date of the financial information and the reported amounts of revenue and expenses during the reporting period.  Although these estimates are based on management's best knowledge of the amounts, events or actions, actual results ultimately may differ from these estimates.  The estimates and underlying assumptions are as follows:

Investment entities

The judgements, assumptions and estimates involved in the Company's accounting policies that are considered by the Board to be the most important to the portrayal of its financial condition are the fair valuation of the investment and the assessment regarding investment entities.  The investment portfolio is held at fair value.  The Directors review the valuations policies, process and application to individual investments.

Entities that meet the definition of an investment entity within IFRS 10 are required to account for most investments in controlled entities, as well as investments in associates and joint ventures, at fair value through profit and loss.  The Board has concluded that the Company continues to meet the definition of an investment entity as its strategic objective of investing in portfolio investments for the purpose of generating returns in the form of investment income and capital appreciation remains unchanged.

Fair value is the underlying principle and is defined as "the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date".  Fair value is therefore an estimate and, as such, determining fair value requires the use of judgement.  The quoted assets in our portfolio are valued at their closing bid price at the statement of financial position date.  The largest investment in the portfolio, however, is represented by an unquoted investment.

Impairment of assets

The Company's principal investments are in wholly owned unquoted subsidiaries which each have a minority interest in overseas entities with energy assets.

The Company is required to test, on an annual basis, whether its non-current assets have suffered any impairment.  Determining whether these assets are impaired requires an estimation of the value in use of the cash-generating units to which the assets have been allocated.  The value in use calculation requires the Directors to estimate the future cash flows expected to arise from the cash-generating unit and a suitable discount rate to calculate the present value.  Subsequent changes to the cash generating unit allocation or to the timing of cash flows could impact on the carrying value of the respective assets.

The calculation of value-in-use for energy assets under development or in production is most sensitive to the following assumptions:

- Commercial reserves

- production volumes;

- commodity prices;

- fixed and variable operating costs;

- capital expenditure; and

- discount rates.

A potential change in any of the above assumptions may cause the estimated recoverable value to be lower than the carrying value, resulting in an impairment loss.  The assumptions which would have the greatest impact on the recoverable amounts of the fields are production volumes and commodity prices

Share based payments

The estimates of share-based payments requires that management selects an appropriate valuation model and make decisions on various inputs into the model including the volatility of its own share price, the probable life of the options before exercise and behavioural consideration of employees.

Deferred tax assets

Deferred taxation is provided for using the liability method.  Deferred tax assets are recognised in respect of tax losses where the Directors believe that it is probable that future profits will be relieved by the benefit of tax losses brought forward.  The Board considers the likely utilisation of such losses by reviewing budgets and medium-term plans for the Company.  The Directors have decided that no deferred tax asset should be recognised at 31 December 2023.  If the actual profits earned by the Company differs from the budgets and forecasts used then the value of such deferred tax assets may differ from that shown in these financial statements.

 

4.         REVENUE

            Segmental reporting

The Company is an Investing Company.  The results for this continuing operation, all of which were carried out in the UK, are disclosed in the Income Statement.  The net assets as at 31 December 2023 as shown on the Statement of Financial Position all relate to the Investment activity.

 

5.         OTHER OPERATING INCOME

		2023		2022
		£		£
Consultancy fees		36,936		-

 

6.         EMPLOYEES AND DIRECTORS

		2023		2022
		£		£
Wages and salaries		464,802		484,633
Social security costs		48,244		56,425
Other pension costs		5,483		10,140
Share-based payments		296,191		179,971
		814,720		731,169

 

The average number of employees during the year was as follows:

		2023		2022
		Number		Number
Directors		4		4
Staff		3		3
		7		7

Under the Pensions Act 2008, every employer must put certain staff into a pension scheme and contribute to it.  The Company auto-enrolled its eligible employees in a defined contribution scheme.  The charge to the Statement of Profit or Loss represents the amounts paid to the scheme.  At the year end, the amount due to the pension scheme was £nil (2022: £nil).

Details of Directors' remuneration can be found in note 24.

7.         NET FINANCE COSTS

		2023		2022
		£		£
Finance income
Interest receivable on group loan		515,044		321,805
Bank interest receivable		4,938		2,247
		519,982		324,052
Finance costs
Loan interest payable		240,709		166,718
Bank loan interest		-		821
Interest on overdue tax		347		5,484
		241,056		173,023
Net finance income		278,926		151,029

PXOG Marshall Limited
Registered office: 60 Gracechurch Street, London EC3V 0HR
Nature of business: Investment entity	% holding
Ordinary shares	100.00
			2023		2022
			£		£
Aggregate capital and reserves			15,544,831		16,014,540
(Loss)/profit for the year			(469,709)		9,367,335
The underlying value of PXOG Marshall Limited is based on the underlying value of the Selva Malvezzi Production Concession, Po Valley, Italy, of which it owned 37% at the year end.  Consistent with prior years, a discounted cash flow ("DCF") model was produced at the year end, based on proved and probable (2P) reserves supported by a Competent Person Report (CPR) produced in 2022.  The DCF model has been updated to reflect forward gas prices as at 31 December 2023 using the Dutch TTF Gas Futures contracts for 2024 and subsequent production years.  The DCF model has also been updated to account for a decelerated annual production rate which lengthens the cashflow period from 10 years to 15 years.  The decreased annual production rate is based on actual and planned production rates.  The DCF cashflows were discounted at 10% p.a.  In addition, consistent with the prior year, a risked valuation of 2C contingent resources in the Selva North and South fields in the 2022 CPR has been updated and included.  With the achievement of 1st production at the Podere Maiar 1 well, and successful conversion of the exploration licence to a production licence, the likelihood of realising the contingent resources, which are on the same production licence, has increased.  This has resulted in an increase in the valuation of these resources.
PXOG Muirhill Limited
Registered office: 60 Gracechurch Street, London EC3V 0HR
Nature of business: Investment entity	% holding
Class of shares:
Ordinary shares	100.00
			2023		2022
			£		£
Aggregate capital and reserves			3,415		17,311
(Loss)/profit for the year			(13,896)		37,295

PXOG Muirhill Limited holds its interests in the Tesorillo and El Romeral projects through its holdings of A and B shares respectively in Tarba Energía S.L. Consistent with the prior year, these investments are being held at the cost of investment in Prospex Energy Limited and in PXOG Muirhill Limited.

All of the subsidiaries are incorporated in the UK and registered in England & Wales.

Investments are recognised and de-recognised on the date when their purchase or sale is subject to a relevant contract and the associated risks and rewards have been transferred.  The Company manages its investments with a view to profiting from the receipt of investment income and capital appreciation from changes in the fair value of investments.

All investments are initially recognised at the fair value of the consideration given and, with the exception of PXOG Muirhill Limited, are subsequently measured at fair value through profit and loss.

Unquoted investments, including both equity and loans are designated at fair value through profit and loss and are subsequently carried in the statement of financial position at fair value.  Fair value is determined in line with the fair value guidelines under IFRS.

In accordance with IFRS 10, the proportion of the investment portfolio held by the Company's unconsolidated subsidiaries is presented as part of the fair value of investment entity subsidiaries, along with the fair value of their other assets and liabilities.

The holding period of the Company's investment portfolio is on average greater than one year.  For this reason, the portfolio is classified as non-current.  It is not possible to identify with certainty investments that will be sold within one year.

Investments in investment entity subsidiaries are accounted for as financial instruments at fair value through profit and loss and are not consolidated in accordance with IFRS10.

These entities hold the Company's interests in investments in portfolio companies.  The fair value can increase or reduce from either cash flows to/from the investment entities or valuation movements in line with the Company's valuation policy.

The fair value of these entities is their net asset values.

The Directors determine that in the ordinary course of business, the net asset values of an investment entity subsidiary are considered to be the most appropriate to determine fair value.  At each reporting period, they consider whether any additional fair value adjustments need to be made to the net asset values of the investment entity subsidiaries.  These adjustments may be required to reflect market participants' considerations about fair value that may include, but are not limited to, liquidity and the portfolio effect of holding multiple investments within the investment entity subsidiary.

13.       TRADE AND OTHER RECEIVABLES

		2023		2022
		£		£
Current:
Trade debtors		3,346		-
Amounts owed by group undertakings		6,185,765		5,496,676
Other debtors		-		1,883
VAT		6,926		5,760
Prepayments and accrued income		5,056		10,918
		6,201,093		5,515,237

 

The Directors consider that the carrying amount of trade and other receivables approximates to their fair value.

14.       CURRENT ASSET INVESTMENTS

		2023		2022
Shares held for sale		£		£
Shares in group undertakings		100		100

The investment in PXOG Massey Limited is held at £100, based on the SPA agreement which is pending completion of sale to H2Oil Limited.  In August 2020, Prospex signed a sale and purchase agreement ('SPA') with H2Oil Limited ('H2Oil') regarding the sale of the entire issued share capital of PXOG Massey Limited ('Massey').  Under the terms of the SPA, the Company will receive up to £215,000 in cash in respect of historical debt owed to the Company by Massey and nominal consideration for shares in Massey of which 85% of the funds (£182,650) had been received by Prospex by 31 December 2020.  As at the statement of financial position date, although it is still expected, the final condition of the SPA had not been met.

Should the final condition of the SPA (being the approval of the regulator in Romania for the transfer of the asset) not be met, the asset would need to be reinstated at fair value which is considered to be higher than the carrying value.  The Directors have taken a prudent view not to recognise this asset at fair value unless it is virtually certain that the final condition of the SPA will not be met.

 

 

15.       CASH AND CASH EQUIVALENTS

		2023		2022
		£		£
Bank accounts		3,186		1,482,762

 

The Directors consider that the carrying amount of cash and cash equivalents approximates to their fair value.  All of the Company's cash and cash equivalents are at floating rates of interest.

 

16.       CALLED UP SHARE CAPITAL

 

	2023		2022			2023		2022
	Number		Number			£		£
Allotted, called up and fully paid
Ordinary shares of 0.1p each - new	332,584,535			278,847,512		332,585		278,848
Deferred shares of 0.1p each	942,462,000			942,462,000		942,462		942,462
Deferred shares of £24 each	54,477			54,477		1,307,459		1,307,459
Deferred shares of 0.9p each	285,785,836			285,785,836		2,572,073		2,572,073
Deferred shares of £4.80 each	442,719		442,719			2,125,051		2,125,051
						7,279,630		7,225,893

 

Share issues

In January 2023, options over 850,400 were exercised, and 450,400 and 400,000 new ordinary shares of £0.001 each were issued at a price of 4 pence per share and 5 pence per share respectively, raising £38,017 before expenses.

In February 2023, 666,684 new ordinary shares of £0.001 were issued at a price of 3.00 pence each on the exercise of warrants, raising £20,000 before expenses.

During the year, 45,476,551 and 6,743,388 new ordinary shares of £0.001 were issued at a price of 4.25 pence each and 5.50 pence each respectively on the conversion of loan notes, valued at £2,303,639 including capitalised interest.

Deferred shares rights

The deferred shares have no rights to vote, attend or speak at general meetings of the Company or to receive any dividend or other distribution and have limited rights to participate in any return of capital on a winding-up or liquidation of the Company.

 

17.       TRADE AND OTHER PAYABLES

		2023		2022
		£		£
Current:
Trade creditors		28,889		-
Social security and other taxes		9,358		15,419
Accruals and deferred income		87,870		26,021
		126,117		41,440

The Directors consider that the carrying amount of trade and other payables approximates to their fair value.

July 2022 Convertible Loan note

The July 2022 Convertible Loan Notes totalling £1.87 million pay interest at 12% per annum, on a quarterly basis.  The first interest payment on 30 September 2022 was capitalised and added to the loan principal.

The July 2022 Convertible Loan Notes, together with capitalised interest, were all converted into 45,476,551 new ordinary shares of 0.1p at 4.25p per ordinary share during 2023.

September 2022 Convertible Loan note

The September 2022 Convertible Loan Notes totalling £0.5 million pay interest at 15% per annum, on a quarterly basis.  The first interest payment on 30 September 2022 was capitalised and added to the loan principal.

The September 2022 Convertible Loan Notes are convertible at 5.50p per ordinary share at any time at the election of the Noteholder.  During 2023, £188,745 of the September 2023 Convertible Loan Notes, including capitalised interest, were converted into 3,431,734 new ordinary shares of 0.1p each.

In December 2023, £182,141 September 2023 Convertible Loan Notes were converted into 3,113,654 new ordinary shares of 0.1p each.

19        DEFERRED TAXATION

 

		2023		2022
		£		£
At 1 January 2023		1,258,809		40,394
On revaluation of investments		(331,151)		1,218,415
At 31 December 2023		927,658		1,258,809

 

20.       FINANCIAL INSTRUMENTS

 

The principal financial instruments used by the Company, from which financial instrument risk arises are as follows:

- Trade and other receivables

- Cash and cash equivalents

- Trade and other payables

A summary of the financial instruments held by category is provided below:

	2023		2022
Financial assets measured at amortised costs:	£		£
Trade and other receivables	10,272		7,643
Cash and cash equivalents	3,186		1,482,762
Amounts owing from group undertakings	6,185,765		5,496,676
	6,199,223		6,987,081

 

	2023		2022
Financial liabilities measured at amortised costs:	£		£
Unsecured loan notes	168,487		2,611,889
Trade and other payables	126,117		41,440
Total financial liabilities	294,604		2,653,329

Financial assets at fair value through profit or loss

Financial instruments that are measured at fair value are classified using a fair value hierarchy that reflects the source of inputs used in deriving the fair value.  The three classification levels are:

- Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;

- Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and

- Level 3: inputs for the asset or liability that are not based on observable market data (unobservable market inputs).

The following table presents the Company's assets carried at fair value by valuation method:

The financial assets at fair value through profit and loss are the Company's holdings in subsidiary undertakings  and one unquoted security and within Level 3 of the fair value hierarchy.

The fair value is determined to be equal to the cost of the investment and is reviewed periodically based on information available about the performance of the underlying business.  Where cost is deemed to be inappropriate, the following table shows the valuation technique used in measuring Level 3 fair values for financial instruments measured at fair value in the statement of financial position, as well as the significant unobservable inputs used.  The only method used is that of NPV.

Valuation technique	Significant unobservable inputs	Inter-relationship between significant unobservable inputs and fair value measurement
NPV - The valuation model considers the present value of expected receipts, discounted using a risk-adjusted discount rate.  The expected receipt is determined by considering the possible scenarios of forecast revenue and gas prices, the amount to be received under each scenario and the probability of each scenario.	Forecast annual revenue growth rate  Forecast gas prices Risk-adjusted discount rate	The estimated fair value would increase (decrease) if: - the annual revenue growth rate were higher (lower); - the gas prices were higher (lower); or - the risk-adjusted discount rate were lower (higher). Generally, a change in the any of the above variables would be accompanied by a directionally similar change in revenue receipts and a consequential change in the valuation of the investment

Financial risk management

The Company's activities expose it to a variety of risks including market risk (foreign currency risk and interest rate risk), credit risk and liquidity risk.  The Company manages these risks through an effective risk management programme and through this programme, the Board seeks to minimise potential adverse effects on the Company's financial performance.

The Board provides written objectives, policies and procedures with regards to managing currency and interest risk exposures, liquidity and credit risk including guidance on the use of certain derivative and non-derivative financial instruments.

Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations.  The Company's credit risk is primarily attributable to its receivables and its cash deposits.  It is Company policy to assess the credit risk of new customers before entering contracts.  The credit risk on liquid funds is limited because the counterparties are banks with high credit-ratings assigned by international credit-rating agencies.

 

Liquidity risk and interest rate risk

Liquidity risk arises from the Company's management of working capital.  It is the risk that the Company will encounter difficulty in meeting its financial obligations as they fall due.  The Board regularly receives cash flow projections for a minimum period of 12 months, together with information regarding cash balances monthly.

The Company is principally funded by equity and invests in short-term deposits, having access to these funds at short notice.  The Company's policy throughout the period has been to minimise interest rate risk by placing funds in risk free cash deposits but also to maximise the return on funds placed on deposit.

All cash deposits attract a floating rate of interest.  The benchmark rate for determining interest receivable and floating rate assets is linked to the UK base rate.

Foreign currency exposure

At 31 December 2023, the Company's monetary assets and liabilities are denominated in GBP Sterling, the functional currency of the Company and therefore at the year end the company had no exposure to net currency gains and losses.

Although the Company's subsidiary undertakings operate in the Eurozone and the Company provides working capital to those companies, it has no formal policies in place to hedge the Company's activities to the exposure to currency risk.  It is the Company's policy to ensure that it enters into transactions in its functional currency wherever possible.

Management regularly monitor the currency profile and obtain informal advice to ensure that the cash balances are held in currencies which minimise the impact on the results and position of the Company from foreign exchange movements.

21.       RELATED PARTY DISCLOSURES

 

Included in loans to group undertakings is an amount of £13 (2022: £13) due from PXOG Massey Limited, the Company's wholly owned subsidiary.  

Included in trade and other receivables is an amount of £5,510,556 (2022: £4,821,467) due from PXOG Marshall Limited, the Company's wholly owned subsidiary.  Interest receivable of £515,044 (2022: £324,805) has been accounted for in the Statement of Profit or Loss.

Included in trade and other receivables is an amount of £675,196 (2022: £675,196) due from PXOG Muirhill Limited, the Company's wholly owned subsidiary.

Included in trade and other receivables is an amount of £3,346 (2022: £nil) due from Tarba Energía S.L. ("Tarba").  Mark Routh is a director of Tarba. 

At the statement of financial position date, the Directors had the following interests in the unsecured loan notes (note 18):

		2023		2022
		£		£
Mark Routh		-		51,164
Richard Mays (resigned 7 February 2023)		-		87,589
William Smith		-		51,164
Alasdair Buchanan		-		51,042

 

 

 

22.       ULTIMATE CONTROLLING PARTY

In the opinion of the Directors, there is no ultimate controlling party.

23.       SHARE-BASED PAYMENT TRANSACTIONS

Share options

At 31 December 2022 and 31 December 2023 outstanding awards to subscribe for ordinary shares of 0.1p each in the Company, granted in accordance with the rules of the share option scheme, were as follows:

 

		Number of shares		Weighted average remaining contractual life (years)		Weighted average exercise price (pence)
2023
Brought forward		11,464,813		2.84		6.61
Granted during the year		7,900,000				-
Exercised during the year		(850,400)				-
Lapsed during the year		(600,529)				-
Carried forward		17,913,884		3.12		8.05

 

		Number of shares		Weighted average remaining contractual life (years)		Weighted average exercise price (pence)
2022
Brought forward		5,820,544		1.46		6.27
Granted during the year		10,300,000				-
Exercised during the year		(4,654,131)				-
Lapsed during the year		(1,600)				-
Carried forward		11,464,813		2.84		6.61

 

All options were exercisable at the year end.  850,400 options were exercised during the year.

The following share-based payment arrangements were in existence at the year-end.

	Options		Number	Expiry date	Exercise price	Fair value at grant date
1	Granted 16 April 2015		113,884	15/04/2025	76.25p	1.94p
2	Granted 18 March 2022		6,300,000	18/03/2025	5.00p	2.10p
3	Granted 23 September 2022		3,600,000	23/09/2027	8.15p	2.91p
4	Granted 28 February 2023		3,700,000	27/02/2028	12.25p	5.18p
5	Granted 26 July 2023		4,200,000	25/07/2028	7.00p	2.49p

 

The fair value of remaining share options has been calculated using the Black Scholes model.  The assumptions used in the calculation of the fair value of the share options outstanding during the year are as follows:

23.       SHARE-BASED PAYMENT TRANSACTIONS - continued

	Options	Grant date share price	Exercise price	Expected volatility	Expected option life (years)	Risk-free interest rate
1	Granted 16 April 2015	100.00p	76.25p	71.50%	3.00	0.71%
2	Granted 18 March 2022	3.85p	5.00p	89.40%	2.00	1.21%
3	Granted 23 September 2022	7.85p	8.15p	87.40%	2.00	4.03%
4	Granted 28 February 2023	11.54p	12.25p	87.20%	3.00	3.73%
5	Granted 26 July 2023	6.25p	7.00p	79.90%	3.00	4.52%

The fair value has been calculated assuming that there will be no dividend yield.

Volatility was determined by reference to the standard deviation of expected share price returns based on a statistical analysis of daily share prices over a 3-year period to grant date.  All of the above options are equity settled.

All of the share options are equity settled and the charge for the year is £296,191 (2022: £187,417).

Warrants

At 31 December 2022 and 31 December 2023, outstanding warrants to subscribe for ordinary shares of 0.1p each in the Company, granted in accordance with the warrant instruments issued by Prospex, were as follows:

 

		Number of shares		Weighted average remaining contractual life (years)		Weighted average exercise price (pence)
2023
Brought forward		666,684		0.23		3.00
Exercised in the year		(666,684)				3.00
Carried forward		-		-		-

 

		Number of shares		Weighted average remaining contractual life (years)		Weighted average exercise price (pence)
2022
Brought forward		27,245,000		1.22		3.03
Exercised during the year		(26,253,316)				3.02
Lapsed during the year		(325,000)				10.00
Carried forward		666,684		0.23		3.00

 

All warrants were exercised during the year.

 

24.       DIRECTORS' EMOLUMENTS

Key management personnel are those persons having authority and responsibility for planning, directing and controlling activities of the Company, including all directors of the Company.

 

		2023		2022
		£		£
Salaries and other short-term employee benefits		278,350		254,833
Share-based payment		169,406		163,994
		447,756		418,827

 

	Salaries and fees	Benefits in kind	Share-based payment	2023	2022
	£	£	£	£	£
Mark Routh	217,500	7,017	93,757	318,274	252,927
William Smith	28,000	-	26,635	54,635	61,300
Alasdair Buchanan	23,333	-	26,635	49,968	52,300
Andrew Hay - appointed 19 April 2023	-	-	22,379	22,379	-
Richard Mays - resigned 7 February 2023	2,500	-	-	2,500	52,300
	271,333	7,017	169,406	447,756	418,827

 

The Directors interests in share options as at 31 December 2023 are as follows:

Director	Number of share options	Exercise price	Date of grant	First date of exercise	Final date of exercise
Mark Routh	2,100,000	5.00p	18/03/2022	18/03/2022	18/03/2025
Mark Routh	900,000	8.15p	23/09/2022	23/09/2022	23/09/2027
Mark Routh	1,233,333	12.25p	28/02/2023	28/02/2023	27/02/2028
Mark Routh	1,200,000	7.00p	26/07/2023	26/07/2023	25/07/2028
	5,433,333
William Smith	21,669	76.25p	14/04/2015	14/04/2015	14/04/2025
William Smith	900,000	5.00p	18/03/2022	18/03/2022	18/03/2025
William Smith	900,000	8.15p	23/09/2022	23/09/2022	23/09/2027
William Smith	370,000	12.25p	28/02/2023	28/02/2023	27/02/2028
William Smith	300,000	7.00p	26/07/2023	26/07/2023	25/07/2028
	2,491,669
Alasdair Buchanan	900,000	5.00p	18/03/2022	18/03/2022	18/03/2025
Alasdair Buchanan	900,000	8.15p	23/09/2022	23/09/2022	23/09/2027
Alasdair Buchanan	370,000	12.25p	28/02/2023	28/02/2023	27/02/2028
Alasdair Buchanan	300,000	7.00p	26/07/2023	26/07/2023	25/07/2028
	2,470,000
Andrew Hay	900,000	7.00p	26/07/2023	26/07/2023	25/07/2028
	900,000

 

25.       EVENTS AFTER THE REPORTING PERIOD

 

All remaining interest-bearing debt outstanding at the reporting date, and accrued interest, was repaid to debt-holders by 31 March 2024.  No further debt or equity raises have occurred between the reporting date and the date of this report.